Earnings History Data for Protara Therapeutics (TARA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Protara Therapeutics
Protara Therapeutics Inc. is committed to identifying and advancing transformative therapies for rare and specialty diseases. The company's portfolio includes, TARA-002, an investigational cell therapy being developed for the treatment of lymphatic malformations, and intravenous Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. Protara Therapeutics Inc., formerly known as ArTara Therapeutics, is based in NEW YORK, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | TARA | Protara Therapeutics | 52.00 | -0.50 | -0.50 | 0.00 | Protara Therapeutics GAAP EPS of -$0.50 beats by $0.02 [11/12/2024 9:15 AM] |
2.62 | 0.04 (1.74%) |
0.0 | 0.0 (0.00%) |
1.04 - 5.24 | 115,442 | 150,000 | 0 | ||
| 06-08-2024 | PM | TARA | Protara Therapeutics | 42.00 | -0.45 | -0.82 | 0.00 | Protara Therapeutics GAAP EPS of -$0.45 [8/6/2024 9:27 AM] |
2.07 | 0.0 (0.00%) |
2.04 | -0.03 (-1.45%) |
1.04 - 5.24 | 70,792 | 100,000 | 304 | ||
| 03-08-2023 | PM | TARA | Protara Therapeutics | 28.00 | -1.00 | -0.97 | 0.00 | Protara Therapeutics GAAP EPS of -$1.00 [8/3/2023 1:55 PM] |
2.54 | 0.03 (1.20%) |
2.60 | 0.09 (3.59%) |
2.20 - 4.60 | 4,383 | 40,000 | 159 | ||
| 09-08-2022 | PM | TARA | Protara Therapeutics | 36.00 | -0.80 | -1.13 | 0.00 | 3.22 | -0.07 (-2.13%) |
3.20 | -0.09 (-2.74%) |
2.72 - 8.63 | 11,315 | 20,000 | 500 | |||
|
|
||||||||||||||||||
| 04-11-2021 | PM | TARA | Protara Therapeutics | 78.00 | -0.96 | -1.15 | 0.00 | 7.02 | -0.02 (-0.28%) |
7.21 | 0.17 (2.41%) |
6.18 - 27.51 | 42,246 | 150,000 | 1,893 | |||
| 05-08-2021 | PM | TARA | Protara Therapeutics, Inc. | 88.00 | -1.14 | -1.14 | 0.00 | ArTara Therapeutics EPS misses by $0.09 [8/5/2021 9:05 AM] |
7.81 | 0.23 (3.03%) |
0.0 | 0.0 (0.00%) |
7.52 - 27.55 | 19,044 | 50,000 | 0 | ||
| 06-05-2021 | PM | TARA | Protara Therapeutics, Inc. | 117.00 | -1.20 | -0.92 | 0.00 | ArTara Therapeutics EPS misses by $0.47 [5/6/2021 8:00 AM] |
9.78 | -0.59 (-5.69%) |
10.23 | -0.14 (-1.35%) |
9.55 - 67.08 | 169,502 | 300,000 | 2,667 | ||
| 11-03-2021 | PM | TARA | Protara Therapeutics, Inc. | 83.63 | -0.79 | -0.42 | 0.00 | ArTara Therapeutics EPS misses by $0.25 [3/11/2021 8:05 AM] |
16.90 | 0.96 (6.02%) |
0.0 | 0.0 (0.00%) |
12.51 - 67.08 | 122,073 | 91,511 | 0 | ||
| 12-11-2020 | PM | TARA | Protara Therapeutics, Inc. | 119.92 | -1.26 | 0.00 | -3.20 | ArTara Therapeutics EPS misses by $0.51 [11/12/2020 7:28 AM] |
20.88 | 0.34 (1.63%) |
20.11 | -0.44 (-2.14%) |
8.82 - 67.08 | 58,579 | 64,820 | 380 | ||
|
|
||||||||||||||||||